• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项表征艰难梭菌响应抗生素治疗时形态变化的实验方案。

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment.

作者信息

Endres Bradley, Bassères Eugénie, Rashid Tasnuva, Chang Long, Alam M Jahangir, Garey Kevin W

机构信息

Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy.

Department of Electrical and Computer Engineering, University of Houston.

出版信息

J Vis Exp. 2017 May 25(123):55383. doi: 10.3791/55383.

DOI:10.3791/55383
PMID:28570548
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5608145/
Abstract

Assessment of antibiotic action with new drug development directed towards anaerobic bacteria is difficult and technically demanding. To gain insight into possible MOA, morphologic changes associated with antibiotic exposure can be visualized using scanning electron microscopy (SEM). Integrating SEM imaging with traditional kill curves may improve our insight into drug action and advance the drug development process. To test this premise, kill curves and SEM studies were conducted using drugs with known but different MOA (vancomycin and metronidazole). C. difficile cells (R20291) were grown with or without the presence of antibiotic for up to 48 h. Throughout the 48 h interval, cells were collected at multiple time points to determine antibiotic efficacy and for imaging on the SEM. Consistent with previous reports, vancomycin and metronidazole had significant bactericidal activity following 24 h of treatment as measured by colony-forming unit (CFU) counting. Using SEM imaging we determined that metronidazole had significant effects on cell length (> 50% reduction in cell length for each antibiotic; P< 0.05) compared to controls and vancomycin. While the phenotypic response to drug treatment has not been documented previously in this manner, they are consistent with the drug's MOA demonstrating the versatility and reliability of the imaging and measurements and the application of this technique for other experimental compounds.

摘要

评估针对厌氧菌的新药开发中的抗生素作用既困难又对技术要求很高。为了深入了解可能的作用机制,可以使用扫描电子显微镜(SEM)观察与抗生素暴露相关的形态学变化。将SEM成像与传统的杀菌曲线相结合,可能会增进我们对药物作用的了解,并推动药物开发进程。为了验证这一前提,我们使用了具有已知但不同作用机制的药物(万古霉素和甲硝唑)进行了杀菌曲线和SEM研究。艰难梭菌细胞(R20291)在有或没有抗生素存在的情况下培养长达48小时。在整个48小时期间,在多个时间点收集细胞,以确定抗生素疗效并用于SEM成像。与先前的报道一致,通过菌落形成单位(CFU)计数测量,万古霉素和甲硝唑在治疗24小时后具有显著的杀菌活性。通过SEM成像,我们确定与对照和万古霉素相比,甲硝唑对细胞长度有显著影响(每种抗生素处理后细胞长度减少>50%;P<0.05)。虽然此前尚未以这种方式记录药物治疗的表型反应,但它们与药物的作用机制一致,证明了成像和测量的通用性和可靠性,以及该技术在其他实验化合物中的应用。

相似文献

1
A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment.一项表征艰难梭菌响应抗生素治疗时形态变化的实验方案。
J Vis Exp. 2017 May 25(123):55383. doi: 10.3791/55383.
2
A novel method for imaging the pharmacological effects of antibiotic treatment on Clostridium difficile.一种用于成像抗生素治疗艰难梭菌药理作用的新方法。
Anaerobe. 2016 Aug;40:10-4. doi: 10.1016/j.anaerobe.2016.04.013. Epub 2016 Apr 21.
3
Evaluating the Effects of Surotomycin Treatment on Clostridium difficile Toxin A and B Production, Immune Response, and Morphological Changes.评估苏拉霉素治疗对艰难梭菌毒素A和B产生、免疫反应及形态学变化的影响。
Antimicrob Agents Chemother. 2016 May 23;60(6):3519-23. doi: 10.1128/AAC.00211-16. Print 2016 Jun.
4
Bactericidal activity of telavancin, vancomycin and metronidazole against Clostridium difficile.替考拉宁、万古霉素和甲硝唑对艰难梭菌的杀菌活性。
Anaerobe. 2010 Jun;16(3):220-2. doi: 10.1016/j.anaerobe.2009.12.002. Epub 2010 Jan 4.
5
[Assessment of susceptibility to metronidazole and vancomycin of Clostridium difficile strains isolated between 1998-2002].[1998年至2002年间分离出的艰难梭菌菌株对甲硝唑和万古霉素的敏感性评估]
Med Dosw Mikrobiol. 2003;55(3):253-8.
6
Time-dependent killing of Clostridium difficile by metronidazole and vancomycin.
J Antimicrob Chemother. 1991 Jan;27(1):55-62. doi: 10.1093/jac/27.1.55.
7
Subinhibitory concentrations of metronidazole increase biofilm formation in Clostridium difficile strains.亚抑菌浓度的甲硝唑会增加艰难梭菌菌株的生物膜形成。
Pathog Dis. 2016 Mar;74(2). doi: 10.1093/femspd/ftv114. Epub 2015 Dec 9.
8
Comparison of the in vitro antibacterial activity of Ramizol, fidaxomicin, vancomycin, and metronidazole against 100 clinical isolates of Clostridium difficile by broth microdilution.通过肉汤微量稀释法比较拉米唑、非达霉素、万古霉素和甲硝唑对100株艰难梭菌临床分离株的体外抗菌活性。
Diagn Microbiol Infect Dis. 2018 Nov;92(3):250-252. doi: 10.1016/j.diagmicrobio.2018.06.002. Epub 2018 Jun 19.
9
In vitro activity of rifaximin, metronidazole and vancomycin against Clostridium difficile and the rate of selection of spontaneously resistant mutants against representative anaerobic and aerobic bacteria, including ammonia-producing species.利福昔明、甲硝唑和万古霉素对艰难梭菌的体外活性以及对包括产氨菌在内的代表性厌氧和需氧菌自发耐药突变体的选择率。
Chemotherapy. 2000 Jul-Aug;46(4):253-66. doi: 10.1159/000007297.
10
In vitro effect of metronidazole and vancomycin in combination on Clostridium difficile.甲硝唑与万古霉素联合使用对艰难梭菌的体外作用
J Antimicrob Chemother. 2009 May;63(5):1076. doi: 10.1093/jac/dkp048. Epub 2009 Feb 24.

引用本文的文献

1
Potent Antimicrobial Activity of Fermentate Against Toxigenic Strains of .发酵产物对……产毒菌株的强效抗菌活性。 (原文此处不完整,缺少具体的菌株名称)
Antibiotics (Basel). 2025 Mar 22;14(4):333. doi: 10.3390/antibiotics14040333.
2
In Vitro and In Vivo Activity of AS101 against Carbapenem-Resistant .AS101对耐碳青霉烯类药物的体外和体内活性
Pharmaceuticals (Basel). 2021 Aug 21;14(8):823. doi: 10.3390/ph14080823.
3
Human-Derived Bifidobacterium dentium Modulates the Mammalian Serotonergic System and Gut-Brain Axis.人源双歧杆菌齿龈亚种可调节哺乳动物的血清素能系统和肠-脑轴。
Cell Mol Gastroenterol Hepatol. 2021;11(1):221-248. doi: 10.1016/j.jcmgh.2020.08.002. Epub 2020 Aug 12.

本文引用的文献

1
Ridinilazole: a novel therapy for Clostridium difficile infection.利福昔明:一种治疗艰难梭菌感染的新型疗法。
Int J Antimicrob Agents. 2016 Aug;48(2):137-43. doi: 10.1016/j.ijantimicag.2016.04.026. Epub 2016 May 30.
2
A novel method for imaging the pharmacological effects of antibiotic treatment on Clostridium difficile.一种用于成像抗生素治疗艰难梭菌药理作用的新方法。
Anaerobe. 2016 Aug;40:10-4. doi: 10.1016/j.anaerobe.2016.04.013. Epub 2016 Apr 21.
3
Clostridium difficile infection: a review of current and emerging therapies.艰难梭菌感染:当前及新出现疗法的综述
Ann Gastroenterol. 2016 Apr-Jun;29(2):147-54. doi: 10.20524/aog.2016.0006.
4
Evaluating the Effects of Surotomycin Treatment on Clostridium difficile Toxin A and B Production, Immune Response, and Morphological Changes.评估苏拉霉素治疗对艰难梭菌毒素A和B产生、免疫反应及形态学变化的影响。
Antimicrob Agents Chemother. 2016 May 23;60(6):3519-23. doi: 10.1128/AAC.00211-16. Print 2016 Jun.
5
Impact on toxin production and cell morphology in Clostridium difficile by ridinilazole (SMT19969), a novel treatment for C. difficile infection.新型艰难梭菌感染治疗药物瑞地那唑(SMT19969)对艰难梭菌毒素产生及细胞形态的影响
J Antimicrob Chemother. 2016 May;71(5):1245-51. doi: 10.1093/jac/dkv498. Epub 2016 Feb 18.
6
In the Endemic Setting, Clostridium difficile Ribotype 027 Is Virulent But Not Hypervirulent.在地方病环境中,艰难梭菌核糖体分型027具有致病性,但并非高致病性。
Infect Control Hosp Epidemiol. 2015 Nov;36(11):1318-23. doi: 10.1017/ice.2015.187. Epub 2015 Aug 20.
7
Burden of Clostridium difficile infection in the United States.美国艰难梭菌感染的负担
N Engl J Med. 2015 Feb 26;372(9):825-34. doi: 10.1056/NEJMoa1408913.
8
Investigation of potentially pathogenic Clostridium difficile contamination in household environs.家庭环境中潜在致病性艰难梭菌污染的调查。
Anaerobe. 2014 Jun;27:31-3. doi: 10.1016/j.anaerobe.2014.03.002. Epub 2014 Mar 19.
9
Evaluation of the effect of oritavancin on Clostridium difficile spore germination, outgrowth and recovery.评估奥利万星对艰难梭菌孢子发芽、生长和复苏的影响。
J Antimicrob Chemother. 2013 Sep;68(9):2078-82. doi: 10.1093/jac/dkt160. Epub 2013 Jun 11.
10
New EMA guideline for antimicrobial development.
Lancet Infect Dis. 2012 Apr;12(4):265-6. doi: 10.1016/S1473-3099(12)70046-4.